Not denying the possibility, but not assuming it either
Within that trial, the body-composition substudy showed that fat mass declined proportionally far more than lean mass, and the ratio of fat-to-lean loss was in line with what has been reported for semaglutide and tirzepatide
Another is the identification of novel biomarkers that might offer even more precise indicators of response, allowing for hyper-personalized 5-Amino-1MQ dosage adjustments in future research
The compound shows high enzymatic selectivity, preserves lean mass, and engages longevity-related pathways (e.g., SIRT1), but remains a nonFDA-approved research substance that is WADA-banned and should be used under medical guidance
Dosage may be reduced to 0.5 mL weekly in patients experiencing gastrointestinal intolerance or increased to a maximum of 2 mL twice weekly for short-term metabolic intensification when supervised by a qualified clinician